For more information on any of the studies listed below, or to make a referral, please call (212) 263-2481 or email research@AboutOurKids.org. For general information read, Q&A About Research Participation. Click here to view research studies that are NOT currently recruiting.
ADHD | Adolescent Depression | Autism Spectrum Disorders | Healthy Controls | Suicidal Behaviors | Temper Outburst Study | Tourette's Disorder |
ADHD
Recruiting Children and Teens Ages 6-17 with ADHD and without ADHDChildren and teenagers between the ages of 6-17 with ADHD, as well as control participants (typically developing children without ADHD), are being recruited for a study on brain function. No-cost evaluations are provided. For more information, please contact Jessica (212) 263-4723.
Adolescent Depression
The Neurobiology of Adolescent Depression Using fMRI and 1H-MRS
We are recruiting adolescents with major depression and healthy participants, ages 12-19, for two studies that investigate the neurobiology of adolescent depression through non-invasive neuroimaging techniques. The first study uses functional Magnetic Resonance Imaging (fMRI) to examine brain activation in response to performing simple tasks. The second study uses Proton Magnetic Resonance Spectroscopy (1H-MRS) to identify neurochemical alterations in the brains of adolescents with major depression. Compensation will be provided for time and travel.
For more information, please contact Benjamin Ely at (212) 263-2494.
Omega-3 Fatty Acids in Adolescents with Depression
Recruiting Adolescents with Depression (PDF)
Information Sheet for Physicans, Schools and Professionals (PDF)
Adolescents, ages 12–19, with depression for 6 weeks or longer, are being evaluated for participation in a new NCCAM/NIH-funded study conducted by Vilma Gabbay, M.D. The purpose of this study is to evaluate if a daily dietary supplement of omega-3 fatty acids (fish oils) has a beneficial effect in the treatment of depression in adolescents. If you are interested in learning more about the study, or in having your teenager evaluated for depression, please contact Benjamin Ely at (212) 263-2494.
Autism Spectrum Disorder
Brain Study on High-Functioning Autism or Asperger Syndrome
This study is for adults between the ages of 18 and 55 who have a diagnosis (or a suspected diagnosis) of an autism spectrum disorder. The study will include a no-cost diagnostic and cognitive assessment, as well as a brain scan at an NYU imaging facility. To learn more about this study, please contact Kritika at 212-263-2497 or kritika.nayar@nyumc.org. Participants receive a written report that summarizes the evaluation. Compensation is provided. Please see the attached flyer for more information.
Brain Study of Children Between 2-5 with Known or Suspected Autism Spectrum Disorder
This study is for children between the ages of 2 and 5 years who have symptoms of autism spectrum disorders, such as poor communication skills and unusual repetitive interests. No-cost assessment includes an evaluation of the child's general abilities and behavior. Compensation is provided. To know more about this study, please contact Erin at (212) 263-2480 or erin.denio@nyumc.org.
Recruiting Children Ages 6-17 with and without High-functioning Autism or Asperger's
Children between the ages of 6 and 17 with high functioning autism or Asperger's, as well as control participants (typically developing children without high functioning autism or Asperger's), are being recruited for a study on brain function. No-cost evaluations are provided. For more information, please contact Samantha at (212) 263-2792 or samantha.ashinoff@nyumc.org.
Healthy Controls
Recruiting Typically Developing Children and Teens Ages 2-17
Children and teenagers between the ages of 2-17 with typical development are being recruited for a study on brain function. No-cost evaluations are provided. For more information, please contact Abby at (212) 263-4714 or Rachel at (212) 263-3692.
Suicidal Behaviors
Immune System Activation in Adolescent Suicide
Funded by the American Foundation for Suicide Prevention (AFSP), this study investigates cytokine, or chemical messengers in the immune system, in three subject groups: 1) suicidal depressed, 2) non-suicidal depressed, and 3) healthy participants, both genders, ages 12-19. Study participation involves a one-time blood draw, urine sample, and evaluation with the investigator for depression and suicidality. Compensation will be provided for time and travel. For more information, please contact Benjamin Ely at (212) 263-2494.
Temper Outburst Study
Evaluation of Children with Temper Outbursts
The NYU Child Study Center is currently conducting a brain imaging study of children with temper outbursts that are difficult to control. If your child has these types of difficulties, and is between five and nine years old, he or she may qualify for this research study. The study provides a free evaluation and summary report. Participation is voluntary and compensation is provided. Please contact Rachel at (212) 263-3692 or rachel.chizkov@nyumc.org for more details.
Tourette's Disorder
Guanfacine (Intuniv) Study
Children and adolescents between the ages of 6 and 17 are being evaluated for participation in a double blind pilot drug trial. The aim of the study is to determine whether extended release guanfacine is safe and beneficial in the treatment of children and adolescents with Tourette's Disorder (TD) or Chronic Tic Disorder. Participants must meet criteria for TD or chronic tic disorder. For more information, please contact Resham Gellatly at (212)263-4764.
MRS GABA Study
Adolescents between the ages of 12 and 17 are being evaluated for participation in an exploratory research study. The aim of this study is to use functional MRI and magnetic resonance spectroscopy (MRS) to evaluate changes in levels of a neurotransmitter, Gamma amino butyric acid (GABA), in the brain. Participants must be right handed and must meet criteria for TD. This study is recruiting participants at both NYU and NKI. For more information, please contact Resham Gellatly at (212)263-4764.
ADHD-TD or ADHD-CTD Treatment Investigation
Children and adolescents between the ages of 9 and 17 are being evaluated for participation in a research pilot trial. This study is investigating the most effective ways to treat tics in children with chronic tic disorders and ADHD. Treatment with a combination of Methylphenidate (MPH) and Cognitive Behavioral Therapy (CBIT) is a current clinical standard of care for treatment of ADHD with comorbid TD or CTD in adolescents. Subjects will be followed as they receive this treatment; the actual treatment is not a study procedure. Participants must have a diagnosis of TD of chronic tic disorder and comorbid ADHD. For more information, please contact Resham Gellatly at (212)263-4764.
fMRI Pilot Study
Children and adolescents, between the ages of 8 to 17, are being evaluated for participation in an exploratory research study. The aim of this study is to use fMRI and DTI to investigate changes in brain networks related to Tourette's Disorder. Participants must be right handed and must meet criteria for TD. For more information, please contact Resham Gellatly at (212)263-4764.
